Antiparasites Flashcards
1
Q
Antamebics
A
- Luminal: Act on parasite in bowel lumen
- Systemic: Active both in intestinal wall and liver
- Mixed: Active against both luminal & systemic disease
- metro & tinidazole
2
Q
Metronidazole
A
- Amebicide of choice for treating invasive amebiasis
- Patients should receive a luminal amebicide in addition after treatment with metronidazole
Other Clinical Applications
- Giardia lamblia
- Trichomonas vaginalis
- Anaerobic cocci
- Anaerobic Gram-negative bacilli
- Combination regimens for H.pylori eradication
MOA
- Once absorbed, metronidazole is non-enzymatically reduced by reacting with reduced ferredoxin
- This reduction causes the production of cytotoxic compounds
- The cytotoxic compounds bind to proteins & DNA, resulting in unstable molecules and cell death
PK
- Oral
- Well distributed (inc. vaginal & seminal fluids, saliva, breast milk & CSF)
- Undergoes hepatic oxidation & glucuronidation (CYP P450’s)
3
Q
Metro - Adverse
A
- GI distress
- Disulfiram-like reaction (avoid alcohol intake) • Unpleasant metallic taste
- Oral moniliasis
- Dark coloration of urine
- Leukopenia, dizziness, ataxia.
- Safety in pregnancy NOT established
4
Q
Tinidazole
A
- 2nd generation nitroimidazole
- Similar to metronidazole but better tolerated and has shorter treatment course
Clinical Applications
- Amebiasis
- Amebic liver abscess
- Giardiasis
- Trichomoniasis
5
Q
Tinidazole - Adverse
A
Same as metronidazole but reports indicate shorter duration of effects with tinidazole
6
Q
Luminal antiamebics
A
- Diloxanide furoate
- Iodoquinol
- Paromomycin
7
Q
Diloaxanide furoate
A
- Used as sole agent for treatment of asymptomatic amebiasis
- Converted in gut to diloxanide freebase active form
- Adverse Effects: Mild (GI distress)
- Not currently available in US – however remains luminal amebicide of choice
8
Q
Iodoquinol
A
- Orally active against luminal trophozoite and cyst forms of E.histolytica
- Used as an alternative to diloxanide furoate for mild- severe infections
9
Q
Iodoquinol - Adverse
A
- Rash, diarrhea, dose-related peripheral neuropathy
- Long term use should be avoided (due to risk of optic neuritis)
10
Q
Paromomycin including Adverse
A
- Aminoglycoside antibiotic
- Effective only against luminal forms of E.histolytica and tapeworm
- Sometimes used with tetracyclines for mild intestinal disease
- Alternative agent for cryptosporidiosis in AIDS patient
- Amebicidal (causes cell membranes to leak)
- Interferes with bacterial protein synthesis (binds to 30S ribosomal subunits)
- Reduces intestinal flora population
Adverse Effects
- GI distress & diarrhea
- Systemic absorption may lead to headaches, dizziness, rashes and arthralgia
11
Q
Systemic antiamebics
A
- Chloroquine
- Emetine
- Dehydroemetine
- Useful for treating liver abscesses or intestinal wall infections
12
Q
Chloroquine
A
- Used in combination with metronidazole & diloxanide furoate
- **Indication: **severe intestinal infection w E. Histolytica
- MOA: Eliminates trophozoites in liver abscesses
13
Q
Emetine and Dihydroemetine
A
- Backup drugs for treatment of severe intestinal or hepatic amebiasis
- Used in combination with a luminal agent
- MOA: Inhibit protein synthesis by blocking ribosomal movement along messenger RNA
PK
- IM or SC
- Concentrate in liver (persists for 1 month)
- Slowly metabolized & eliminated
14
Q
Emetine and Dihydroemetine - Adverse
A
- Pain at site of injection
- Transient nausea
- Cardiotoxicity
- Neuromuscular weakness
- Dizziness
- Rash
15
Q
Amebiasis Rx
A
- Asymptomatic, intestinal infection: Diloxanide furoate
- Mild-moderate intestinal infection: Metronidazole + diloxanide furoate
- Severe intestinal infection: metro or tinidazole + diloxanide furoate
- Hepatic abscess & other extraintestinal disease: Metronidazole or tinidazole + diloxanide furoate